![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
F.i.s. - Fabbrica Italiana Sintetici S.p.a. Montecchio Maggiore It, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Tetrazepam, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2008-152 - Rev 00
This Chemical Type CEP, issued on February 13, 2015, remains in force until March 22, 2023, ensuring its reliability within the pharmaceutical industry.
Substance Number 1738 associated with this CEP further emphasizes